{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:57:25Z","timestamp":1791190645489,"version":"4.1.0"},"reference-count":92,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T00:00:00Z","timestamp":1362700800000},"content-version":"vor","delay-in-days":8194,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharma"],"published-print":{"date-parts":[[1990,10]]},"abstract":"<jats:p>In comparison with many of the other drug delivery systems, implantable pumps and implants for variable rate delivery are at a crude stage of development. Although exceptions exist, the typical implantable pump consists of an electromechanically complex mechanism to regulate drug delivery from a percutaneous refillable reservoir, while power to drive the system comes from a transcutaneous energy transmission system. The potential for electrical or mechanical failure is high, and the systems are not yet sufficiently convenient or easy to use to recommend in a routine therapy. Problems with refilling of an apparently well designed implanted reservoir have been observed while, at the same time, cutaneous energy transmission systems are not well established.<\/jats:p><jats:p>In most instances, the development of an elementary osmotic pump system dosage form follows a well defined path of physical\u2014chemical formulation and clinical testing. The benefits most often provided by the dosage form are expected to be (1) increase in selectivity of drug action achieved by the system's zero\u2010order release rate, and (2) decrease in frequency of administration.<\/jats:p><jats:p>The success in achieving these values is quantifiable from the pharmacology of the drug substance and its pharmacokinetics. Osmotic and other technical approaches to producing economical, rate\u2010controlled dosage forms will make it possible for all new parmaeceutical products to carry kinetic specification of rate as well as static specification of content. This review considers the characteristics of the ideal implantable pump, the clinical situations which require pumps, the limitations of portable pumps, and the detailed characteristics of existing implantable pumps and implants. Most of the review, however, focuses on insulin delivery because of the importance of this subject.<\/jats:p>","DOI":"10.1002\/j.1552-4604.1990.tb03566.x","type":"journal-article","created":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T21:41:57Z","timestamp":1362778917000},"page":"871-889","source":"Crossref","is-referenced-by-count":24,"title":["Drug Delivery Systems 4. Implants in Drug Delivery"],"prefix":"10.1002","volume":"30","author":[{"given":"Vasant V.","family":"Ranade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,3,8]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"45","volume-title":"Controlled Drug Delivery Vol. II Clinical Applications.","author":"Bruck SD","year":"1983"},{"key":"e_1_2_1_3_2","first-page":"1","volume-title":"Controlled Drug Delivery Vol II Clinical Applications","author":"Lawrence WH","year":"1983"},{"key":"e_1_2_1_4_2","first-page":"129","volume-title":"Medical Applications of Controlled Release","author":"Sefton MV","year":"1984"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.78.3.1863"},{"key":"e_1_2_1_6_2","unstructured":"MerrillEW:1981. U.S. Patent 3 608 540."},{"key":"e_1_2_1_7_2","first-page":"1","article-title":"Polymers as surgical implants","author":"Leininger RI","year":"1973","journal-title":"CRC Crit Rev Bioeng"},{"key":"e_1_2_1_8_2","volume-title":"Biocompatibility of Clinical Implant Materials","author":"Williams DF","year":"1981"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.4.2.319"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(81)90425-3"},{"key":"e_1_2_1_11_2","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2337\/diab.28.7.634","article-title":"Control of blood glucose in experimental diabetes by means of totally implantable insulin infusion device","volume":"28","author":"Blackshear PJ","year":"1979","journal-title":"Diabetes"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.4.2.325"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19800301)45:5<866::AID-CNCR2820450507>3.0.CO;2-3"},{"key":"e_1_2_1_14_2","volume-title":"Alzet mini\u2010osmotic pump bibliography","year":"1981"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1159\/000123059"},{"key":"e_1_2_1_16_2","unstructured":"EllinwoodEH:1975. U.S. Patent 3 923 060."},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1109\/TBME.1981.324696"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1982.03320380040026"},{"key":"e_1_2_1_19_2","doi-asserted-by":"crossref","unstructured":"CarlsonGA ShaferBD UrendaRS SpencerWJ SadlerRCA EatonRP: inOstranderLE (Ed.):A new low power high\u2010reliability infusion pump. Proceedings of the New England Bioengineering Conference1979;193.","DOI":"10.1016\/B978-0-08-024634-5.50055-8"},{"key":"e_1_2_1_20_2","first-page":"523","article-title":"Development of an artificial beta cell suitable for animal implantation","volume":"26","author":"Carlson GA","year":"1980","journal-title":"ASAIO Trans"},{"key":"e_1_2_1_21_2","unstructured":"LoveJT GoanaJL:An implantable insulin delivery system. InCohenBA (Ed.):Frontiers of Engineering in Health Care 1981;51."},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.3.2.345"},{"key":"e_1_2_1_23_2","doi-asserted-by":"crossref","unstructured":"SummersGD:1970. U.S. Patent 3 527 220.","DOI":"10.1136\/bmj.3.5721.527-a"},{"key":"e_1_2_1_24_2","first-page":"51","article-title":"The design and initial testing of an implantable infusion pump","volume":"134","author":"Blackshear PJ","year":"1972","journal-title":"Surg Gynaecol Obstet"},{"key":"e_1_2_1_25_2","unstructured":"BlackshearPJ DormanFD BlackshearPL BuchwaldH VarcoRL1973. U.S. Patent 3 731 681."},{"key":"e_1_2_1_26_2","first-page":"176","article-title":"One year of continuous heparinization in the dog using a totally implantable infusion pump","volume":"141","author":"Blackshear PJ","year":"1975","journal-title":"Surg Gynaecol Obstet"},{"key":"e_1_2_1_27_2","first-page":"229","article-title":"Design and initial testing of a totally implantable transcutaneously controllable insulin delivery device","volume":"24","author":"Perkins PR","year":"1978","journal-title":"ASAIO Trans"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.3.2.351"},{"key":"e_1_2_1_29_2","first-page":"510","article-title":"Chronic heparin anticoagulant in dogs by continuous infusion with a totally implantable pump","volume":"216","author":"Rohde TD","year":"1975","journal-title":"ASAIO Trans"},{"key":"e_1_2_1_30_2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1177\/039139888000300112","article-title":"Insulin delivery and the artificial beta cell: luminal obstruction in capillary conduits","volume":"3","author":"Loughheed W","year":"1980","journal-title":"Int J Artif Organs"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600641218"},{"key":"e_1_2_1_32_2","unstructured":"StolzenbergSJ LinkenhermerWH1971. U.S. Patent 3 604 417."},{"key":"e_1_2_1_33_2","first-page":"120","volume-title":"Drug Delivery Systems. Fundamentals and Techniques","author":"Ray N","year":"1987"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02584524"},{"key":"e_1_2_1_35_2","first-page":"143","volume-title":"Topics in Pharmaceutical Sciences","author":"Nau H","year":"1985"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(81)90541-5"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0041-008X(85)90081-X"},{"key":"e_1_2_1_38_2","first-page":"2011","article-title":"Improved therapeutic index of bleomycin when administered by continuous infusion in mice","volume":"62","author":"Sikic BI","year":"1978","journal-title":"Cancer Treat Rep"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pa.24.040184.001215"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(85)91036-4"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198602000-00004"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198210000-00015"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(85)90544-1"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1159\/000123059"},{"key":"e_1_2_1_45_2","first-page":"14","article-title":"Stimulating ovarian function in exotic carnivores with pulses of GnRH","author":"Lasley BL","year":"1983","journal-title":"Ann Proc Amer Assoc Zoo Vet"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1002\/jez.1402340315"},{"key":"e_1_2_1_47_2","first-page":"67","article-title":"Implantation of a closed loop artificial beta cell","volume":"27","author":"Bessman JP","year":"1981","journal-title":"ASAIO Trans"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02443331"},{"key":"e_1_2_1_49_2","first-page":"55","article-title":"Implantable insulin delivery system","author":"Schapiro GA","year":"1979","journal-title":"Medical Electronics"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1021\/i300001a001"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.820150613"},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1594.1978.tb03470.x"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.820170605"},{"key":"e_1_2_1_54_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00258302"},{"key":"e_1_2_1_55_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1981.03310320031019"},{"key":"e_1_2_1_56_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4613-2745-5_25"},{"key":"e_1_2_1_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4731(79)90066-9"},{"key":"e_1_2_1_58_2","first-page":"141","volume-title":"Hormonal Factors in Fertility, Infertility, and Contraception","author":"Benagiano G","year":"1982"},{"key":"e_1_2_1_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(81)90743-2"},{"key":"e_1_2_1_60_2","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod28.1.186"},{"key":"e_1_2_1_61_2","first-page":"232","volume":"28","author":"Pitt CG","year":"1980","journal-title":"Natl Inst Drug Abuse Res Monogr Ser"},{"key":"e_1_2_1_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(83)91204-8"},{"key":"e_1_2_1_63_2","first-page":"307","volume":"101","author":"Croxatto HB","year":"1982","journal-title":"Acta Endocrinol"},{"key":"e_1_2_1_64_2","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0015-0282(16)47120-7","volume":"39","author":"Sivan I","year":"1983","journal-title":"Stern J Fertil Steril"},{"key":"e_1_2_1_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(79)90089-1"},{"key":"e_1_2_1_66_2","first-page":"139","volume-title":"Delivery Systems, Fundamentals and Techniques.","author":"Blackshear PJ","year":"1987"},{"key":"e_1_2_1_67_2","first-page":"149","article-title":"The implantable infusion pump: A new concept in drug delivery","volume":"6","author":"Blackshear PJ","year":"1979","journal-title":"Med Prog Technol"},{"key":"e_1_2_1_68_2","doi-asserted-by":"publisher","DOI":"10.1038\/scientificamerican1279-66"},{"key":"e_1_2_1_69_2","first-page":"111","volume-title":"Controlled Drug Delivery","author":"Blackshear PJ","year":"1984"},{"key":"e_1_2_1_70_2","first-page":"520","volume-title":"Methods in Enzymology.","author":"Blackshear PJ","year":"1985"},{"key":"e_1_2_1_71_2","first-page":"530","volume-title":"Methods in Enzymology","author":"Blackshear PJ","year":"1985"},{"key":"e_1_2_1_72_2","first-page":"82","article-title":"A programmable implantable system (PIMS) for the treatment of diabetes","volume":"7","author":"Fischell RE","year":"1983","journal-title":"Artif Organs"},{"key":"e_1_2_1_73_2","first-page":"131","volume-title":"Artificial Systems for Insulin Delivery","author":"Blackshear PJ","year":"1983"},{"key":"e_1_2_1_74_2","unstructured":"CitronP:Benefits of programmable implanted drug administration the latest developments in drug delivery systems. 1987 Conference Proceedings Pharmaceutical Technology 20\u201322."},{"key":"e_1_2_1_75_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01930381"},{"key":"e_1_2_1_76_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.3883493"},{"key":"e_1_2_1_77_2","first-page":"481","volume-title":"Chronobiology: Principles and Applications to Shifts in Schedules.","author":"Levi F","year":"1980"},{"key":"e_1_2_1_78_2","article-title":"Time of day modified continuous FUDR infusion, using an implanted programmable pump, improves therapeutic index","author":"Roemeling RV","year":"1986","journal-title":"ASCO Proceedings"},{"key":"e_1_2_1_79_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1984.61.2.0302"},{"key":"e_1_2_1_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8619(18)31048-X"},{"key":"e_1_2_1_81_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1987.66.2.0181"},{"key":"e_1_2_1_82_2","unstructured":"RoemelingRV HrusheskyW:Circadian shaping of FUDR infusion reduces toxicity even at high\u2010dose intensity. ASCO Proceedings1987(abstract)."},{"key":"e_1_2_1_83_2","first-page":"96","article-title":"Osmotically actuated dosage forms for rate\u2010controlled drug delivery","volume":"11","author":"Eckenhoff B","year":"1987","journal-title":"Pharm Tech"},{"key":"e_1_2_1_84_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600661009"},{"key":"e_1_2_1_85_2","unstructured":"UrquhartJ:Methods of drug administration in Proceedings of the National Academy of Sciences Institute of Medicine Conference on Pharmaceuticals for Developing Countries 1979;329\u2013348."},{"key":"e_1_2_1_86_2","unstructured":"DedrickRL LutzRJ ZaharkoDS:1976. U.S. Patent 3 946 734."},{"key":"e_1_2_1_87_2","unstructured":"SchopflinG:1977. U.S. Patent 4 012 497."},{"key":"e_1_2_1_88_2","unstructured":"EllinwoodEH:1977. U.S. Patent 4 003 379."},{"key":"e_1_2_1_89_2","unstructured":"KuhlD LuftG:1979. U.S. Patent 4 140 122."},{"key":"e_1_2_1_90_2","unstructured":"WichterleO:1976. U.S. Patent 3 971 378 and 1975 3 896 806."},{"key":"e_1_2_1_91_2","unstructured":"MichaelsAS BashwaJD ZaffaroniA:1975. U.S. Patent 3 901 232 Michaels AS: 1974 U.S. Patent 3 788 322."},{"key":"e_1_2_1_92_2","unstructured":"Proceedings of the 14th Internet. Symp. Control. Rel. Bioact. Mater. August 2\u20135 1987 LeePI LeonhardtBA Eds.: Toronto Canada."},{"key":"e_1_2_1_93_2","unstructured":"Program & Abstracts of the 15th Internat. Symp. Control. Rel. Bioact. Mater. August 15\u201319 1988 Basel Switzerland."}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1552-4604.1990.tb03566.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/j.1552-4604.1990.tb03566.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T13:34:12Z","timestamp":1697981652000},"score":1,"resource":{"primary":{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/10.1002\/j.1552-4604.1990.tb03566.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,10]]},"references-count":92,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1990,10]]}},"alternative-id":["10.1002\/j.1552-4604.1990.tb03566.x"],"URL":"https:\/\/doi.org\/10.1002\/j.1552-4604.1990.tb03566.x","archive":["Portico"],"relation":{},"ISSN":["0091-2700","1552-4604"],"issn-type":[{"value":"0091-2700","type":"print"},{"value":"1552-4604","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,10]]}}}